Johnson & Johnson News

Johnson & Johnson | 8-K: Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization

May 1 19:04

Johnson & Johnson | 8-K: Amended and Restated By-Laws and Poll Results of 2024 Stockholders Meeting

Apr 30 04:38

Johnson & Johnson | 8-K/A: Johnson & Johnson Reports Q1 2024 Results (Amendment)

Apr 17 00:20

Johnson & Johnson | 8-K: Johnson & Johnson Reports Q1 2024 Results and Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%

Apr 16 19:10

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Apr 6 05:32

Johnson & Johnson | DEFA14A: Others

Mar 13 19:43

Johnson & Johnson | DEFA14A: Others

Mar 13 19:38

Johnson & Johnson | DEF 14A: Definitive information statements

Mar 13 19:38

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Feb 16 06:28

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 30 05:55

Johnson & Johnson | 8-K: Johnson & Johnson Reports Q4 and Full-Year 2023 Results

Jan 23 13:00

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 9 13:00

Johnson & Johnson | DFAN14A: Definitive additional proxy soliciting materials filed by non-management

Jan 8 13:00

Johnson & Johnson | DEFA14A: Others

Jan 8 13:00

Johnson & Johnson | 8-K: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors

Dec 6, 2023 05:42

Johnson & Johnson | 8-K: Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review

Dec 5, 2023 20:52

Johnson & Johnson | 8-K: Johnson & Johnson MedTech Acquires Laminar, Inc.

Dec 1, 2023 05:30

Johnson & Johnson | 8-K: Johnson & Johnson Deferred Compensation Plan

Nov 28, 2023 05:56

Johnson & Johnson | 8-K: Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

Oct 24, 2023 04:48

Johnson & Johnson | 8-K: Current report

Oct 17, 2023 19:33